Table 5.

Bivariate models between the hyperarousal symptom dimension and individual components of the primary outcome ACM/MACE

Outcomes	n (%)	HR (95% CI)
ACM only	10 (8.8)	2.8 (1.5–5.0)*
MACE only	29 (25.4)	1.5 (1.0–2.2)*
Rehospitalization for MI, UA, and CHF alone	16 (14)	1.7 (1.0–2.7)*
Rehospitalization for revascularization procedures or ICD/PPM placement alone	13 (11.4)	1.4 (0.8−2.3)*
ACM and all MACE combined	39 (34.2)	1.8 (1.3–2.4)*
ACM and all confirmed MACE only	34 (29.8)	1.9 (1.4–2.6)*

ACM, all-cause mortality; MACE, major adverse events; MI, myocardial infarction; UA, unstable angina; CHF, congestive heart failure; ICD, implantable cardioverter-defibrillator; PPM, permanent pacemaker.

*p < .001.